The Therapeutic Effects of Curcumin in Early Septic Acute Kidney Injury: An Experimental Study

Drug Des Devel Ther. 2021 Oct 7:15:4243-4255. doi: 10.2147/DDDT.S332623. eCollection 2021.

Abstract

Purpose: Sepsis is the leading condition associated with acute kidney injury (AKI) in the hospital and intensive care unit (ICU), sepsis-induced AKI (S-AKI) is strongly associated with poor clinical outcomes. Curcumin possesses an ability to ameliorate renal injury from ischemia-reperfusion, but it is still unknown whether they have the ability to reduce S-AKI. The aim of this study was to investigate the protective effects of curcumin on S-AKI and to assess its therapeutic potential on renal function, inflammatory response, and microcirculatory perfusion.

Methods: Male Sprague-Dawley (SD) rats underwent cecal ligation and puncture (CLP) to induce S-AKI and immediately received vehicle (CLP group) or curcumin (CLP+Cur group) after surgery. At 12 and 24h after surgery, serum indexes, inflammatory factors, cardiac output (CO), renal blood flow and microcirculatory flow were measured.

Results: Serum levels of creatinine (Scr), cystatin C (CysC), IL-6 and TNF-α were significantly lower in the CLP+Cur group than those in the CLP group (P < 0.05). Treatment with curcumin improved renal microcirculation at 24h by measurement of contrast enhanced ultrasound (CEUS) quantitative parameters [peak intensity (PI); half of descending time (DT/2); area under curve (AUC); P < 0.05]. In histopathological analysis, treatment with curcumin reduced damage caused by CLP.

Conclusion: Curcumin can alleviate S-AKI in rats by improving renal microcirculatory perfusion and reducing inflammatory response. Curcumin may be a potential novel therapeutic agent for the prevention or reduction of S-AKI.

Keywords: acute kidney injury; contrast enhanced ultrasound; curcumin; inflammation; microcirculation; sepsis.

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Acute Kidney Injury / physiopathology
  • Animals
  • Creatinine / blood
  • Curcumin / pharmacology*
  • Disease Models, Animal
  • Inflammation / drug therapy
  • Inflammation / pathology
  • Male
  • Microcirculation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Renal Circulation / drug effects
  • Sepsis / drug therapy*
  • Sepsis / physiopathology
  • Time Factors

Substances

  • Creatinine
  • Curcumin